cached image

Hugo Moser - Publications

Affiliations: 
Kennedy Krieger Institute, Baltimore, MD, United States 
Area:
Pediatric neurology, leukodystrophies
Website:
http://www.kennedykrieger.org/kki_staff.jsp?pid=1841

90 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Moser AB, Steinberg SJ, Watkins PA, Moser HW, Ramaswamy K, Siegmund KD, Lee DR, Ely JJ, Ryder OA, Hacia JG. Human and great ape red blood cells differ in plasmalogen levels and composition. Lipids in Health and Disease. 10: 101. PMID 21679470 DOI: 10.1186/1476-511X-10-101  0.48
2010 Watkins PA, Moser AB, Toomer CB, Steinberg SJ, Moser HW, Karaman MW, Ramaswamy K, Siegmund KD, Lee DR, Ely JJ, Ryder OA, Hacia JG. Identification of differences in human and great ape phytanic acid metabolism that could influence gene expression profiles and physiological functions. Bmc Physiology. 10: 19. PMID 20932325 DOI: 10.1186/1472-6793-10-19  0.48
2009 Steinberg SJ, Snowden A, Braverman NE, Chen L, Watkins PA, Clayton PT, Setchell KD, Heubi JE, Raymond GV, Moser AB, Moser HW. A PEX10 defect in a patient with no detectable defect in peroxisome assembly or metabolism in cultured fibroblasts. Journal of Inherited Metabolic Disease. 32: 109-19. PMID 19127411 DOI: 10.1007/s10545-008-0969-8  0.48
2009 Smith SA, Golay X, Fatemi A, Mahmood A, Raymond GV, Moser HW, van Zijl PC, Stanisz GJ. Quantitative magnetization transfer characteristics of the human cervical spinal cord in vivo: application to adrenomyeloneuropathy. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 61: 22-7. PMID 19097204 DOI: 10.1002/Mrm.21827  0.32
2008 Pillion JP, Moser HW, Raymond GV. Auditory function in adrenomyeloneuropathy. Journal of the Neurological Sciences. 269: 24-9. PMID 18199457 DOI: 10.1016/j.jns.2007.12.011  0.48
2007 Moser HW, Moser AB, Hollandsworth K, Brereton NH, Raymond GV. "Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy. Journal of Molecular Neuroscience : Mn. 33: 105-13. PMID 17901554  0.48
2007 Mahmood A, Raymond GV, Dubey P, Peters C, Moser HW. Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study. The Lancet. Neurology. 6: 687-92. PMID 17618834 DOI: 10.1016/S1474-4422(07)70177-1  0.48
2007 Eichler F, Mahmood A, Loes D, Bezman L, Lin D, Moser HW, Raymond GV. Magnetic resonance imaging detection of lesion progression in adult patients with X-linked adrenoleukodystrophy. Archives of Neurology. 64: 659-64. PMID 17502464 DOI: 10.1001/Archneur.64.5.659  0.32
2007 Moser HW, Mahmood A. New insights about hematopoietic stem cell transplantation in adrenoleukodystrophy. Archives of Neurology. 64: 631-2. PMID 17502460 DOI: 10.1001/archneur.64.5.631  0.32
2007 Moser HW, Mahmood A, Raymond GV. X-linked adrenoleukodystrophy. Nature Clinical Practice. Neurology. 3: 140-51. PMID 17342190 DOI: 10.1038/ncpneuro0421  0.48
2006 Steinberg SJ, Dodt G, Raymond GV, Braverman NE, Moser AB, Moser HW. Peroxisome biogenesis disorders. Biochimica Et Biophysica Acta. 1763: 1733-48. PMID 17055079 DOI: 10.1016/j.bbamcr.2006.09.010  0.48
2006 Zackowski KM, Dubey P, Raymond GV, Mori S, Bastian AJ, Moser HW. Sensorimotor function and axonal integrity in adrenomyeloneuropathy. Archives of Neurology. 63: 74-80. PMID 16401738 DOI: 10.1001/Archneur.63.1.74  0.48
2006 Cox CS, Dubey P, Raymond GV, Mahmood A, Moser AB, Moser HW. Cognitive evaluation of neurologically asymptomatic boys with X-linked adrenoleukodystrophy. Archives of Neurology. 63: 69-73. PMID 16401737 DOI: 10.1001/archneur.63.1.69  0.48
2005 Moser HW, Raymond GV, Dubey P. Adrenoleukodystrophy: new approaches to a neurodegenerative disease. Jama. 294: 3131-4. PMID 16380594 DOI: 10.1001/jama.294.24.3131  0.48
2005 Powers JM, Pei Z, Heinzer AK, Deering R, Moser AB, Moser HW, Watkins PA, Smith KD. Adreno-leukodystrophy: oxidative stress of mice and men. Journal of Neuropathology and Experimental Neurology. 64: 1067-79. PMID 16319717 DOI: 10.1097/01.jnen.0000190064.28559.a4  0.48
2005 Mahmood A, Dubey P, Moser HW, Moser A. X-linked adrenoleukodystrophy: therapeutic approaches to distinct phenotypes. Pediatric Transplantation. 9: 55-62. PMID 16305618 DOI: 10.1111/j.1399-3046.2005.00447.x  0.4
2005 Dubey P, Fatemi A, Huang H, Nagae-Poetscher L, Wakana S, Barker PB, van Zijl P, Moser HW, Mori S, Raymond GV. Diffusion tensor-based imaging reveals occult abnormalities in adrenomyeloneuropathy. Annals of Neurology. 58: 758-66. PMID 16240348 DOI: 10.1002/Ana.20643  0.48
2005 Moser HW, Raymond GV, Lu SE, Muenz LR, Moser AB, Xu J, Jones RO, Loes DJ, Melhem ER, Dubey P, Bezman L, Brereton NH, Odone A. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil. Archives of Neurology. 62: 1073-80. PMID 16009761 DOI: 10.1001/archneur.62.7.1073  0.48
2005 Smith SA, Golay X, Fatemi A, Jones CK, Raymond GV, Moser HW, van Zijl PC. Magnetization transfer weighted imaging in the upper cervical spinal cord using cerebrospinal fluid as intersubject normalization reference (MTCSF imaging). Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 54: 201-6. PMID 15968676 DOI: 10.1002/Mrm.20553  0.48
2005 Fatemi A, Smith SA, Dubey P, Zackowski KM, Bastian AJ, van Zijl PC, Moser HW, Raymond GV, Golay X. Magnetization transfer MRI demonstrates spinal cord abnormalities in adrenomyeloneuropathy. Neurology. 64: 1739-45. PMID 15911801 DOI: 10.1212/01.Wnl.0000164458.02141.06  0.48
2005 Dubey P, Raymond GV, Moser AB, Kharkar S, Bezman L, Moser HW. Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening. The Journal of Pediatrics. 146: 528-32. PMID 15812458 DOI: 10.1016/j.jpeds.2004.10.067  0.48
2005 Dubey P, Fatemi A, Barker PB, Degaonkar M, Troeger M, Zackowski K, Bastian A, Smith SA, Pomper MG, Moser HW, Raymond GV. Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy. Neurology. 64: 304-10. PMID 15668429 DOI: 10.1212/01.Wnl.0000149514.13580.84  0.48
2004 Kawada Y, Khan M, Sharma AK, Ratnayake DB, Dobashi K, Asayama K, Moser HW, Contreras MA, Singh I. Inhibition of peroxisomal functions due to oxidative imbalance induced by mistargeting of catalase to cytoplasm is restored by vitamin E treatment in skin fibroblasts from Zellweger syndrome-like patients. Molecular Genetics and Metabolism. 83: 297-305. PMID 15589116 DOI: 10.1016/j.ymgme.2004.07.012  0.48
2004 Moser H, Dubey P, Fatemi A. Progress in X-linked adrenoleukodystrophy. Current Opinion in Neurology. 17: 263-9. PMID 15167059 DOI: 10.1097/00019052-200406000-00005  0.4
2004 Moser HW, Fatemi A, Zackowski K, Smith S, Golay X, Muenz L, Raymond G. Evaluation of therapy of X-linked adrenoleukodystrophy. Neurochemical Research. 29: 1003-16. PMID 15139299 DOI: 10.1023/B:Nere.0000021245.12181.90  0.48
2004 Peters C, Charnas LR, Tan Y, Ziegler RS, Shapiro EG, DeFor T, Grewal SS, Orchard PJ, Abel SL, Goldman AI, Ramsay NK, Dusenbery KE, Loes DJ, Lockman LA, Kato S, ... ... Moser HW, et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood. 104: 881-8. PMID 15073029 DOI: 10.1182/blood-2003-10-3402  0.48
2003 Moser HW, Raymond GV, Koehler W, Sokolowski P, Hanefeld F, Korenke GC, Green A, Loes DJ, Hunneman DH, Jones RO, Lu SE, Uziel G, Giros ML, Roels F. Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials. Advances in Experimental Medicine and Biology. 544: 369-87. PMID 14713253  0.48
2003 Loes DJ, Fatemi A, Melhem ER, Gupte N, Bezman L, Moser HW, Raymond GV. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology. 61: 369-74. PMID 12913200 DOI: 10.1212/01.Wnl.0000079050.91337.83  0.48
2003 Fatemi A, Barker PB, UluÄŸ AM, Nagae-Poetscher LM, Beauchamp NJ, Moser AB, Raymond GV, Moser HW, Naidu S. MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy. Neurology. 60: 1301-7. PMID 12707433 DOI: 10.1212/01.Wnl.0000059546.15529.Cb  0.48
2002 Tagawa Y, Laroy W, Nimrichter L, Fromholt SE, Moser AB, Moser HW, Schnaar RL. Anti-ganglioside antibodies bind with enhanced affinity to gangliosides containing very long chain fatty acids. Neurochemical Research. 27: 847-55. PMID 12374222 DOI: 10.1023/A:1020221410895  0.48
2002 Eichler FS, Itoh R, Barker PB, Mori S, Garrett ES, van Zijl PC, Moser HW, Raymond GV, Melhem ER. Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Radiology. 225: 245-52. PMID 12355012 DOI: 10.1148/Radiol.2251011040  0.48
2002 Corzo D, Gibson W, Johnson K, Mitchell G, LePage G, Cox GF, Casey R, Zeiss C, Tyson H, Cutting GR, Raymond GV, Smith KD, Watkins PA, Moser AB, Moser HW, et al. Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disorders. American Journal of Human Genetics. 70: 1520-31. PMID 11992258 DOI: 10.1086/340849  0.48
2002 Eichler FS, Barker PB, Cox C, Edwin D, Ulug AM, Moser HW, Raymond GV. Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy. Neurology. 58: 901-7. PMID 11914405 DOI: 10.1212/Wnl.58.6.901  0.48
2002 Mori S, Kaufmann WE, Davatzikos C, Stieltjes B, Amodei L, Fredericksen K, Pearlson GD, Melhem ER, Solaiyappan M, Raymond GV, Moser HW, van Zijl PC. Imaging cortical association tracts in the human brain using diffusion-tensor-based axonal tracking. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 47: 215-23. PMID 11810663 DOI: 10.1002/Mrm.10074  0.48
2001 Kemp S, Pujol A, Waterham HR, van Geel BM, Boehm CD, Raymond GV, Cutting GR, Wanders RJ, Moser HW. ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations. Human Mutation. 18: 499-515. PMID 11748843 DOI: 10.1002/Humu.1227  0.48
2001 Naidu S, Kaufmann WE, Abrams MT, Pearlson GD, Lanham DC, Fredericksen KA, Barker PB, Horska A, Golay X, Mori S, Wong DF, Yablonski M, Moser HW, Johnston MV. Neuroimaging studies in Rett syndrome. Brain & Development. 23: S62-71. PMID 11738844 DOI: 10.1016/S0387-7604(01)00381-3  0.48
2001 Ito M, Blumberg BM, Mock DJ, Goodman AD, Moser AB, Moser HW, Smith KD, Powers JM. Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation. Journal of Neuropathology and Experimental Neurology. 60: 1004-19. PMID 11589421 DOI: 10.1093/JNEN/60.10.1004  0.48
2001 Watkins PA, Hamilton JA, Leaf A, Spector AA, Moore SA, Anderson RE, Moser HW, Noetzel MJ, Katz R. Brain uptake and utilization of fatty acids: applications to peroxisomal biogenesis diseases. Journal of Molecular Neuroscience : Mn. 16: 87-92; discussion 15. PMID 11478388 DOI: 10.1385/Jmn:16:2-3:87  0.48
2001 Katz R, Hamilton JA, Spector AA, Moore SA, Moser HW, Noetzel MJ, Watkins PA. Brain uptake and utilization of fatty acids: recommendations for future research. Journal of Molecular Neuroscience : Mn. 16: 333-5. PMID 11478387 DOI: 10.1385/Jmn:16:2-3:333  0.48
2001 Bezman L, Moser AB, Raymond GV, Rinaldo P, Watkins PA, Smith KD, Kass NE, Moser HW. Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Annals of Neurology. 49: 512-7. PMID 11310629  0.48
2001 Williard DE, Nwankwo JO, Kaduce TL, Harmon SD, Irons M, Moser HW, Raymond GV, Spector AA. Identification of a fatty acid delta6-desaturase deficiency in human skin fibroblasts. Journal of Lipid Research. 42: 501-8. PMID 11290821  0.48
2001 Melhem ER, Gotwald TF, Itoh R, Zinreich SJ, Moser HW. T2 relaxation measurements in X-linked adrenoleukodystrophy performed using dual-echo fast fluid-attenuated inversion recovery MR imaging. Ajnr. American Journal of Neuroradiology. 22: 773-6. PMID 11290498  0.48
2001 Powers JM, Rosenblatt DS, Schmidt RE, Cross AH, Black JT, Moser AB, Moser HW, Morgan DJ. Neurological and neuropathologic heterogeneity in two brothers with cobalamin C deficiency. Annals of Neurology. 49: 396-400. PMID 11261516 DOI: 10.1002/Ana.78  0.48
2001 Ito R, Melhem ER, Mori S, Eichler FS, Raymond GV, Moser HW. Diffusion tensor brain MR imaging in X-linked cerebral adrenoleukodystrophy. Neurology. 56: 544-7. PMID 11222805 DOI: 10.1212/Wnl.56.4.544  0.48
2001 van Geel BM, Bezman L, Loes DJ, Moser HW, Raymond GV. Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Annals of Neurology. 49: 186-94. PMID 11220738  0.48
2001 Noetzel M, Moser H, Salem N, Martinez M, Raymond G, Powers J, Faust P, Rapoport S, Yavin E, Katz R, Mihalik S, Edmond J. Brain uptake and utilization of fatty acids: Applications to peroxisomal biogenesis disorders (An International Workshop): Roundtable discussion of session 4: The roles of DHA in Zellweger syndrome, a representative peroxisomal biogenesis disorder Journal of Molecular Neuroscience. 16: 317-321. DOI: 10.1385/Jmn:16:2-3:317  0.48
2001 Ingeholm ML, Levine BA, Eichler F, Tu H, Jimenez-Sanchez G, Moser H. A multi-center clinical trial using next generation internet technology Proceedings of Spie - the International Society For Optical Engineering. 4323: 151-158. DOI: 10.1117/12.435470  0.48
2000 Moser HW, Loes DJ, Melhem ER, Raymond GV, Bezman L, Cox CS, Lu SE. X-Linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients. Neuropediatrics. 31: 227-39. PMID 11204280 DOI: 10.1055/S-2000-9236  0.48
2000 Yeager AM, Uhas KA, Coles CD, Davis PC, Krause WL, Moser HW. Bone marrow transplantation for infantile ceramidase deficiency (Farber disease). Bone Marrow Transplantation. 26: 357-63. PMID 10967581 DOI: 10.1038/sj.bmt.1702489  0.48
2000 Lachtermacher MB, Seuanez HN, Moser HW, Smith KD. One-step multiplex PCR strategy for identification of mutations by SSCP and DNA sequencing. Biotechniques. 29: 234-6. PMID 10948421 DOI: 10.2144/00292Bm06  0.48
2000 Santos MJ, Henderson SC, Moser AB, Moser HW, Lazarow PB. Peroxisomal ghosts are intracellular structures distinct from lysosomal compartments in Zellweger syndrome: a confocal laser scanning microscopy study. Biology of the Cell / Under the Auspices of the European Cell Biology Organization. 92: 85-94. PMID 10879629 DOI: 10.1016/S0248-4900(00)89016-4  0.48
2000 Moser HW, Bezman L, Lu SE, Raymond GV. Therapy of X-linked adrenoleukodystrophy: prognosis based upon age and MRI abnormality and plans for placebo-controlled trials. Journal of Inherited Metabolic Disease. 23: 273-7. PMID 10863943 DOI: 10.1023/A:1005688130338  0.48
2000 Melhem ER, Loes DJ, Georgiades CS, Raymond GV, Moser HW. X-linked adrenoleukodystrophy: the role of contrast-enhanced MR imaging in predicting disease progression. Ajnr. American Journal of Neuroradiology. 21: 839-44. PMID 10815658  0.48
1999 Melhem ER, Barker PB, Raymond GV, Moser HW. X-linked adrenoleukodystrophy in children: review of genetic, clinical, and MR imaging characteristics. Ajr. American Journal of Roentgenology. 173: 1575-81. PMID 10584804 DOI: 10.2214/ajr.173.6.10584804  0.48
1999 Chang CC, South S, Warren D, Jones J, Moser AB, Moser HW, Gould SJ. Metabolic control of peroxisome abundance. Journal of Cell Science. 112: 1579-90. PMID 10212151  0.48
1999 Moser HW, Kemp S, Smith KD. Mutational analysis and the pathogenesis of variant X-linked adrenoleukodystrophy phenotypes. Archives of Neurology. 56: 273-5. PMID 10190815  0.48
1999 Moser AB, Jones DS, Raymond GV, Moser HW. Plasma and red blood cell fatty acids in peroxisomal disorders. Neurochemical Research. 24: 187-97. PMID 9972864  0.48
1999 Moser AB, Kreiter N, Bezman L, Lu S, Raymond GV, Naidu S, Moser HW. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Annals of Neurology. 45: 100-10. PMID 9894883  0.48
1998 Moser HW, Raymond GV. Genetic peroxisomal disorders: why, when, and how to test. Annals of Neurology. 44: 713-5. PMID 9818924 DOI: 10.1002/ana.410440502  0.48
1998 Bezman L, Moser HW. Incidence of X-linked adrenoleukodystrophy and the relative frequency of its phenotypes. American Journal of Medical Genetics. 76: 415-9. PMID 9556301 DOI: 10.1002/(SICI)1096-8628(19980413)76:5<415::AID-AJMG9>3.0.CO;2-L  0.32
1997 Kaplan PW, Tusa RJ, Rignani J, Moser HW. Somatosensory evoked potentials in adrenomyeloneuropathy. Neurology. 48: 1662-7. PMID 9191783  0.48
1997 Nagan N, Hajra AK, Das AK, Moser HW, Moser A, Lazarow P, Purdue PE, Zoeller RA. A fibroblast cell line defective in alkyl-dihydroxyacetone phosphate synthase: a novel defect in plasmalogen biosynthesis. Proceedings of the National Academy of Sciences of the United States of America. 94: 4475-80. PMID 9114014 DOI: 10.1073/Pnas.94.9.4475  0.48
1997 Braverman N, Steel G, Obie C, Moser A, Moser H, Gould SJ, Valle D. Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata Nature Genetics. 15: 369-376. PMID 9090381 DOI: 10.1038/ng0497-369  0.48
1997 Bambach BJ, Moser HW, Blakemore K, Corson VL, Griffin CA, Noga SJ, Perlman EJ, Zuckerman R, Wenger DA, Jones RJ. Engraftment following in utero bone marrow transplantation for globoid cell leukodystrophy. Bone Marrow Transplantation. 19: 399-402. PMID 9051254 DOI: 10.1038/sj.bmt.1700665  0.52
1996 Yahraus T, Braverman N, Dodt G, Kalish JE, Morrell JC, Moser HW, Valle D, Gould SJ. The peroxisome biogenesis disorder group 4 gene, PXAAA1, encodes a cytoplasmic ATPase required for stability of the PTS1 receptor. The Embo Journal. 15: 2914-23. PMID 8670792  0.48
1996 Melhem ER, Breiter SN, Ulug AM, Raymond GV, Moser HW. Improved tissue characterization in adrenoleukodystrophy using magnetization transfer imaging. Ajr. American Journal of Roentgenology. 166: 689-95. PMID 8623652 DOI: 10.2214/ajr.166.3.8623652  0.48
1995 Levade T, Tempesta MC, Moser HW, Fensom AH, Harzer K, Moser AB, Salvayre R. Sulfatide and sphingomyelin loading of living cells as tools for the study of ceramide turnover by lysosomal ceramidase--implications for the diagnosis of Farber disease. Biochemical and Molecular Medicine. 54: 117-25. PMID 8581356 DOI: 10.1006/bmme.1995.1017  0.52
1995 Dodt G, Braverman N, Wong C, Moser A, Moser HW, Watkins P, Valle D, Gould SJ. Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders. Nature Genetics. 9: 115-25. PMID 7719337 DOI: 10.1038/ng0295-115  0.48
1995 Watkins PA, McGuinness MC, Raymond GV, Hicks BA, Sisk JM, Moser AB, Moser HW. Distinction between peroxisomal bifunctional enzyme and acyl-CoA oxidase deficiencies. Annals of Neurology. 38: 472-7. PMID 7668838 DOI: 10.1002/ana.410380322  0.48
1995 Watkins PA, Gould SJ, Smith MA, Braiterman LT, Wei HM, Kok F, Moser AB, Moser HW, Smith KD. Altered expression of ALDP in X-linked adrenoleukodystrophy. American Journal of Human Genetics. 57: 292-301. PMID 7668254  0.52
1995 McGuinness MC, Griffin DE, Raymond GV, Washington CA, Moser HW, Smith KD. Tumor necrosis factor-alpha and X-linked adrenoleukodystrophy. Journal of Neuroimmunology. 61: 161-9. PMID 7593551 DOI: 10.1016/0165-5728(95)00084-F  0.48
1994 Kornfeld M, Moser AB, Moser HW, Kleinschmidt-DeMasters B, Nolte K, Phelps A. Solvent vapor abuse leukoencephalopathy. Comparison to adrenoleukodystrophy. Journal of Neuropathology and Experimental Neurology. 53: 389-98. PMID 8021713 DOI: 10.1097/00005072-199407000-00011  0.48
1994 Kruse B, Barker PB, van Zijl PC, Duyn JH, Moonen CT, Moser HW. Multislice proton magnetic resonance spectroscopic imaging in X-linked adrenoleukodystrophy. Annals of Neurology. 36: 595-608. PMID 7944292 DOI: 10.1002/ana.410360408  0.48
1994 Phillips JP, Lockman LA, Shapiro EG, Blazar BR, Loes DJ, Moser HW, Krivit W. CSF findings in adrenoleukodystrophy: correlation between measures of cytokines, IgG production, and disease severity. Pediatric Neurology. 10: 289-94. PMID 7520699 DOI: 10.1016/0887-8994(94)90124-4  0.32
1987 Noetzel MJ, Landau WM, Moser HW. Adrenoleukodystrophy carrier state presenting as a chronic nonprogressive spinal cord disorder. Archives of Neurology. 44: 566-7. PMID 3579671 DOI: 10.1001/archneur.1987.00520170092031  0.48
1986 Kelley RI, Datta NS, Dobyns WB, Hajra AK, Moser AB, Noetzel MJ, Zackai EH, Moser HW. Neonatal adrenoleukodystrophy: new cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy syndromes. American Journal of Medical Genetics. 23: 869-901. PMID 3515938 DOI: 10.1002/Ajmg.1320230404  0.52
1984 Chemke J, Lieberman E, Carmi R, Abarbanel Y, Costeff H, Goldhammer Y, Moser HW. Adrenoleukodystrophy in Israel: a genetic, clinical and biochemical study. Israel Journal of Medical Sciences. 20: 1123-32. PMID 6097565  0.52
1983 Luckenbach MW, Green WR, Miller NR, Moser HW, Clark AW, Tennekoon G. Ocular clinicopathologic correlation of Hallervorden-Spatz syndrome with acanthocytosis and pigmentary retinopathy. American Journal of Ophthalmology. 95: 369-82. PMID 6829683 DOI: 10.1016/S0002-9394(14)78308-4  0.44
1983 Cohen SM, Brown FR, Martyn L, Moser HW, Chen W, Kistenmacher M, Punnett H, de la Cruz ZC, Chan NR, Green WR. Ocular histopathologic and biochemical studies of the cerebrohepatorenal syndrome (Zellweger's syndrome) and its relationship to neonatal adrenoleukodystrophy. American Journal of Ophthalmology. 96: 488-501. PMID 6624831  0.52
1982 Philippart M, Nuwer MR, Mortier W, Moser HW. Value of C26:O fatty acid determination for the diagnosis of atypical adrenoleukodystrophy. Annals of Neurology. 11: 105. PMID 6277233 DOI: 10.1002/ana.410110121  0.52
1974 Moser HW, O'Brien JS, Atkins L, Fuller TC, Kliman A, Janowska S, Russell PS, Bartsocas CS, Cosimi B, Dulaney JT. Infusion of normal HL-A identical leukocytes in Sanfilippo disease type B. Estimate of infused cell survival by assays of alpha-N-acetylglucosaminidase activity and cytogenetic techniques: effect on glycosaminoglycan excretion in the urine. Archives of Neurology. 31: 329-37. PMID 4278147 DOI: 10.1001/archneur.1974.00490410077009  0.44
1969 Moser H. Transitions of metabolic states of animal cells Archiv Der Julius Klaus-Stiftung Fur Vererbungsforschung, Sozialanthropologie Und Rassenhygiene. 44: suppl 28-47. PMID 5409252  0.48
1969 Moser HW, Prensky AL, Wolfe HJ, Rosman NP. Farber's lipogranulomatosis. Report of a case and demonstration of an excess of free ceramide and ganglioside. The American Journal of Medicine. 47: 869-90. PMID 5395479 DOI: 10.1016/0002-9343(69)90202-2  0.44
1968 Prensky AL, Carr S, Moser HW. Development of Myelin in Inherited Disorders of Amino Acid Metabolism: A Biochemical Investigation Archives of Neurology. 19: 552-558. PMID 5726767 DOI: 10.1001/archneur.1968.00480060022002  0.48
1968 Prensky AL, Wolfe HJ, Rosman NP, Moser HW. Biochemical and histochemical studies of a case of Farber's lipogranulomatosis. Journal of Neuropathology and Experimental Neurology. 27: 144. PMID 5656562  0.52
1966 Benton JW, Moser HW, Dodge PR, Carr S. Modification of the schedule of myelination in the rat by early nutritional deprivation. Pediatrics. 38: 801-7. PMID 5954221  0.48
1966 Prensky AL, Moser HW. Brain lipids, proteolipids, and free amino acids in maple syrup urine disease Journal of Neurochemistry. 13: 863-874. PMID 5928229  0.48
1962 KARNOVSKY ML, MAJNO G, MOSER HW, JOEL CD. Defective metabolism of lipids in nervous tissue Progress in Neurobiology. 5: 287-309. PMID 13962568  0.48
1959 KARNOVSKY ML, MOSER H, MAJNO G. Lipid biosynthesis by peripheral and central nervous tissue as a function of age Progress in Neurobiology. 4: 138-158. PMID 14404543  0.48
1958 Moser H, Karnovsky ML. Studies on the biosynthesis of cerebroside galactose Neurology. 8: 81-83. PMID 13541617  0.48
Show low-probability matches.